Buy Stocks Easy | About Us
June 27, 2022
Buy Stocks Easy | Online Stocks

CRBP


Buy Corbus Pharmaceuticals Holdings, Inc. Stock (symbol: CRBP) Easy Online

Company Name: Corbus Pharmaceuticals Holdings, Inc.

Symbol: CRBP

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2014

CRBP Current Share Price

Today's CRBP ( Corbus Pharmaceuticals Holdings, Inc. ) opening price: $5.1600

Yesterday's CRBP ( Corbus Pharmaceuticals Holdings, Inc. ) closing price: $5.1500

Corbus Pharmaceuticals Holdings, Inc. Stock ( symbol: CRBP ) Price Chart since IPO (2014):

12 Months Corbus Pharmaceuticals Holdings, Inc. Stock ( symbol: CRBP ) Price Chart

Popular Questions about Corbus Pharmaceuticals Holdings, Inc. Public Stock ( CRBP )

A: Corbus Pharmaceuticals Holdings, Inc. stock symbol (also called stock or share ticker) is CRBP

A: Corbus Pharmaceuticals Holdings, Inc. IPO (Initial Public Offering) took place on 2014

A: Corbus Pharmaceuticals Holdings, Inc.'s stock (CRBP symbol) price at ther IPO (initial Public Offering) was $5.1600

Q: Is CRBP stock worth buying at the moment?

A: The CRBP stock performance since 2019 are rather disappointing. If you had bought 1 share of Corbus Pharmaceuticals Holdings, Inc. stock (symbol: CRBP) at the beginning of 2019, at the opening share price of $7.5600, you would be left with exactly $5.1600 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Corbus Pharmaceuticals Holdings, Inc. Stock Easy Online

Corbus Pharmaceuticals Holdings, Inc. Stock Ticker Price Chart since IPO:





Corbus Pharmaceuticals Holdings, Inc. Stock Price Yesterday



 


Corbus Pharmaceuticals Holdings, Inc. Stock Price – Last Week




 


Corbus Pharmaceuticals Holdings, Inc. Stock Price – Last Month




 


Corbus Pharmaceuticals Holdings, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/09/1957871/0/en/Corbus-Pharmaceuticals-to-Host-Expert-Symposium-on-the-Therapeutic-Potential-of-Targeting-the-Endocannabinoid-System.html
                            

                                
Corbus Pharmaceuticals to Host Expert Symposium on the Therapeutic Potential of Targeting the Endocannabinoid System

                                
                                
- Live video webcast on Friday, December 13, 2019 from 1:00 PM – 2:...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/18/1948686/0/en/Corbus-Pharmaceuticals-Completes-Enrollment-of-Phase-2b-Study-of-Lenabasum-for-Treatment-of-Cystic-Fibrosis.html
                            

                                
Corbus Pharmaceuticals Completes Enrollment of Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis

                                
                                
Norwood, MA, Nov.  18, 2019  (GLOBE NEWSWIRE) -- Corbus Pharmaceuti...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/12/1945364/0/en/Corbus-Pharmaceuticals-to-Present-at-the-Jefferies-2019-Global-Healthcare-Conference-in-London.html
                            

                                
Corbus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference in London

                                
                                
- Presentation with live audio webcast on Wednesday, November 20th ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/11/1944703/0/en/Corbus-Pharmaceuticals-Updates-Data-from-Lenabasum-Open-Label-Extension-Studies-in-Systemic-Sclerosis-and-Dermatomyositis-at-2019-ACR-Annual-Meeting.html
                            

                                
Corbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual Meeting

                                
                                
               


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4305090-corbus-pharmaceuticals-holdings-inc-crbp-ceo-yuval-cohen-q3-2019-results-earnings-call
                            

                                
Corbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q3 2019 Results - Earnings Call Transcript

                                
                                
Corbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q3 ...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/608643/corbus-pharmaceuticals-crbp-reports-q3-loss-tops-revenue-estimates
                            

                                
Corbus Pharmaceuticals (CRBP) Reports Q3 Loss, Tops Revenue Estimates

                                
                                
Corbus Pharmaceuticals (CRBP) delivered earnings and revenue surpri...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/11/07/is-corbus-pharmaceuticals-stock-a-buy.aspx
                            

                                
Is Corbus Pharmaceuticals Stock a Buy?

                                
                                
It’s full steam ahead with a slate of late-stage clinical trial res...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/11/07/better-buy-gw-pharmaceuticals-vs-corbus-pharmaceut.aspx
                            

                                
Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals

                                
                                
It’s a medical marijuana showdown.


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/07/1943027/0/en/Corbus-Pharmaceuticals-Reports-2019-Third-Quarter-Financial-Results-and-Provides-Clinical-and-Corporate-Updates.html
                            

                                
Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates

                                
                                
Norwood, MA, Nov.  07, 2019  (GLOBE NEWSWIRE) -- Corbus Pharmaceuti...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/04/1940226/0/en/Corbus-Pharmaceuticals-to-Host-Conference-Call-and-Webcast-to-Discuss-Third-Quarter-2019-Operational-and-Financial-Results-on-November-7-2019.html
                            

                                
Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss  Third Quarter 2019 Operational and Financial Results on November 7, 2019

                                
                                
- Company to host conference call and webcast on Thursday, November...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.